Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Polycythemia Vera × Hematopoietic Stem Cell Transplantation × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Leukemia 6 Graft vs Host Disease 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms, Plasma Cell 4 Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Recurrence 2 Primary Myelofibrosis 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Thrombocytopenia 1 Sarcoma, Myeloid 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

fludarabine phosphate 16 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 ruxolitinib 8 Busulfan 8 Cyclophosphamide 7 Tacrolimus 6 fludarabine 5 Melphalan 5 Cyclosporine 5 Methotrexate 4 Antilymphocyte Serum 4 givinostat hydrochloride 3 givinostat 3 Lenalidomide 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 thymoglobulin 2 pomalidomide 2 Surveys and Questionnaires 2 Stem Cell Transplantation 2 Prednisone 2 Hydroxyurea 2 Etoposide 2 Dasatinib 2 Carboplatin 2 veliparib 1 sonidegib 1 pembrolizumab 1 peginterferon alfa-2a 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡